Metaanalysis vs large clinical trials: which should guide our management?

Area of Science:

• Clinical Medicine
• Evidence-Based Practice
• Medical Research Methodology

Background:

• Randomized clinical trials (RCTs) are considered the gold standard for clinical decision-making.
• Meta-analyses combine results from multiple RCTs to provide a summary effect measure.
• Clinicians face dilemmas choosing between RCTs and meta-analyses for evidence-based practice.

Purpose of the Study:

• To explore the benefits and limitations of randomized clinical trials versus meta-analyses.
• To determine the optimal type of evidence for guiding clinical practice.
• To use calcium and aspirin therapy for preeclampsia prevention as a case study.

Main Methods:

• Comparative analysis of evidence types: large randomized clinical trials versus meta-analyses.
• Case study: examining calcium and aspirin therapy for preeclampsia prevention.
• Evaluation of study types for guiding clinical practice.

Main Results:

• Large randomized clinical trials provide robust evidence for clinical guidance.
• Meta-analyses offer valuable summaries but may have limitations.
• The case of preeclampsia prevention highlights the strengths of RCTs.

Conclusions:

• Large randomized clinical trials are the preferred evidence base for clinical practice when available.
• Evidence hierarchy suggests prioritizing large RCTs over meta-analyses for direct clinical application.
• The findings support the primacy of high-quality RCTs in evidence-based medicine.